CPRX
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Angelini Pharma completed its acquisition of Catalyst PharmaceuticalsJul 16, 2026
- Angelini Pharma to acquire Catalyst Pharmaceuticals in $4.1 billion dealMay 7, 2026
- Catalyst Pharmaceuticals settles FIRDAPSE patent litigation with Hetero LabsMay 7, 2026
- Catalyst Pharmaceuticals announces settlement of FIRDAPSE® (amifampridine) patent litigation with Lupin PharmaceuticalsAug 27, 2025
- Catalyst Pharmaceuticals announces settlement of FIRDAPSE® (amifampridine) patent litigation with Lupin PharmaceuticalsAug 25, 2025